In the News

Paulomi Raiji Campbell, Ph.D., Assistant Professor of Clinical Psychiatry & Behavioral Sciences, has been selected to participate in Screening for Psychosocial Distress, a selective two-year training program developed by the American Psychosocial Oncology Society (APOS) and Yale School of Nursing. The goal is to implement screening and measure outcomes at the newly developed Psycho-Oncology program at Vanderbilt Ingram Cancer Center. Campbell was selected along with Rose VIck, MSN, PHMNP-BC, Instructor for the Vanderbilt University School of Nursing, 

Karen Stewart, Ph.D., Assistant Professor of Psychiatry & Behavioral Sciences, and colleagues from Virginia Commonwealth University Institute of Drug and Alcohol Studies recently published a review article on impulsivity and smoking in patients with comorbid mental health concerns.

Kimberly Brown, Ph.D., ABPP, Associate Professor of Clinical Psychiatry & Behavioral Sciences, was recently published in the Journal of Personality Assessment. Brown served as co-author on the article "Use of the Personality Assessment Inventory in Fitness-for-Duty Evaluations of Physicians." Click here to read the article.  

Jenni Blackford, Ph.D., Associate Professor of Psychiatry & Behavioral Sciences, is currently investigating the role of the human BNST circuit in alcohol withdrawal in a study funded by National Institute on Alcohol Abuse and Alcoholism. Serving as co-principal investigator alongside Dr. Blackford is Danny Winder, Ph.D., Professor of Molecular Physiology & Biophysics and Psychiatry & Behavioral Sciences, and serving as co-investigator is Meg Benningfield, M.D., Assistant Professor of Psychiatry & Behavioral Sciences and Pediatrics.

Heather Kreth, Psy.D., Assistant Professor of Clinical Psychiatry & Behavioral Sciences, was recently nominated to the Youth Services Committee of the National Association of Psychiatric Health Systems. Dr. Kreth is the Clinical Director of the Adult & Adolescent Partial Hospitalization Programs.

An invited report by Ariel Y. Deutch, Ph.D., James G. Blakemore Chair and Professor of Psychiatry & Behavioral Sciences and Professor of Pharmacology, was recently published by the DANA Foundation. Dr. Deutch was appointed of Associate Editor of npjSchizophrenia. Click here to read the DANA Foundation report, titled "Finding Clues to Schizophrenia Outside Neurons."

Todd Erik Peters, M.D., Assistant Professor and Associate Chief of Staff of Psychiatry & Behavioral Sciences and Medical Director for Inpatient Services, Vanderbilt Psychiatric Hospital, was named Consulting Editor for Child and Adolescent Psychiatric Clinics of North America.  This publication is considered a top-three publication in the field of child and adolescent psychiatry.  

Warren D. Taylor, M.D., Associate Professor of Psychiatry & Behavioral Sciences, served as co-author on a new paper titled "Frontocingulate cerebral blood flow and cerebrovascular reactivity as predictors of antidepressant response in late-life depression." The paper appears in the Journal of Affective Disorders. The study was directed by Dr. Margarita Abi Zeid Daou, a PGY4 resident in the Department of Psychiatry & Behavioral Sciences, mentored by Dr. Taylor.

Blythe Corbett, Ph.D., Associate  Director of Psychiatry & Behavioral Sciences and Psychology, was recently published in the December 2016 edition of the AMA Journal of Ethics. Her article, "Autism, Art, and Accessibility to Theater," discusses accessibility of the dramatic arts to those on the autism spectrum and uses an attributional model of stigma to explain potential differences in knowledge, attitudes, and behavior toward people with mental illness.

Jonathan E. Becker, D.O., Assistant Professor of Clinical Psychiatry and Behavioral Sciences," served as lead author for the paper "Update on Transcranial Magnetic Stimulation for Depression and Other Neuropsychiatric Illnesses" in the publication Psychiatric Annals. Transcranial magnetic stimulation (TMS) is a neuromodulation technique that was first approved for the treatment of major depressive disorder in 2008. Because of the success of TMS in treating depression, there has been interest in applications for other neuropsychiatric diseases.